Patient-controlled analgesia following caesarean section under general anaesthesia : a comparison of fentanyl with morphine
This prospective, randomised, double-blind study compared PCA fentanyl with PCA morphine for post-Caesarean section analgesia. Following a standardised general anaesthetic, 37 women were allocated to receive either fentanyl (n = 18) or morphine (n = 19). The PCA was commenced after the women had bee...
Gespeichert in:
Veröffentlicht in: | Canadian journal of anaesthesia 1995, Vol.42 (1), p.41-45 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 45 |
---|---|
container_issue | 1 |
container_start_page | 41 |
container_title | Canadian journal of anaesthesia |
container_volume | 42 |
creator | HOWELL, P. R GAMBLING, D. R PAVY, T MCMORLAND, G DOUGLAS, M. J |
description | This prospective, randomised, double-blind study compared PCA fentanyl with PCA morphine for post-Caesarean section analgesia. Following a standardised general anaesthetic, 37 women were allocated to receive either fentanyl (n = 18) or morphine (n = 19). The PCA was commenced after the women had been made comfortable in the postanaesthetic recovery room with the appropriate opioid solution (mean dose required = fentanyl 375 micrograms or morphine 16 mg). Initial PCA settings were bolus 1 ml (fentanyl 25 micrograms or morphine 1 mg), lockout time ten minutes, and no background infusion. Both analgesic solutions provided effective analgesia for a mean of 37 hr with high levels of patient satisfaction, and there were no differences in VAS scores for pain and patient satisfaction, or for side effects (nausea, itch, and sleepiness) between fentanyl or morphine. However, more patients in the fentanyl group required supplementary boluses or alterations to the PCA settings (13/18 vs 4/19: P = 0.005), and one patient was removed from the study due to inadequate analgesia. We conclude that fentanyl is not recommended for routine PCA use following Caesarean section. |
doi_str_mv | 10.1007/BF03010570 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF03010570</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>7889583</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-d7dfb4a469da55220f57fb791b87cd94dfafe11395ce86cdacdc81d7b07921ba3</originalsourceid><addsrcrecordid>eNpFkM9LwzAUx4Moc04v3oUcPAnVpGmbxJsOp8JADwreymt-bJE2LUnHGP7zdm7M04P3_Xzfgw9Cl5TcUkL43eOMMEJJzskRGtNMFomQPD9GYyJYmhSUfJ2isxi_CSGiyMUIjbgQMhdsjH7eoXfG94lqfR_aujYag4d6YaIDbIdFu3Z-gRWYCMGAx9Go3rUer7w2AS-MNwHqbcfEfvnXuseAVdt0EFwcwNZiO3wAv6nx2vVL3LShWzpvztGJhTqai_2coM_Z08f0JZm_Pb9OH-aJYhnvE821rTLICqkhz9OU2JzbiktaCa60zLQFayhlMldGFEqD0kpQzSvCZUorYBN0s7urQhtjMLbsgmsgbEpKyq3A8l_gAF_t4G5VNUYf0L2xIb_e5xAV1DaAVy4eMMYKKknBfgGUwntW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Patient-controlled analgesia following caesarean section under general anaesthesia : a comparison of fentanyl with morphine</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>HOWELL, P. R ; GAMBLING, D. R ; PAVY, T ; MCMORLAND, G ; DOUGLAS, M. J</creator><creatorcontrib>HOWELL, P. R ; GAMBLING, D. R ; PAVY, T ; MCMORLAND, G ; DOUGLAS, M. J</creatorcontrib><description>This prospective, randomised, double-blind study compared PCA fentanyl with PCA morphine for post-Caesarean section analgesia. Following a standardised general anaesthetic, 37 women were allocated to receive either fentanyl (n = 18) or morphine (n = 19). The PCA was commenced after the women had been made comfortable in the postanaesthetic recovery room with the appropriate opioid solution (mean dose required = fentanyl 375 micrograms or morphine 16 mg). Initial PCA settings were bolus 1 ml (fentanyl 25 micrograms or morphine 1 mg), lockout time ten minutes, and no background infusion. Both analgesic solutions provided effective analgesia for a mean of 37 hr with high levels of patient satisfaction, and there were no differences in VAS scores for pain and patient satisfaction, or for side effects (nausea, itch, and sleepiness) between fentanyl or morphine. However, more patients in the fentanyl group required supplementary boluses or alterations to the PCA settings (13/18 vs 4/19: P = 0.005), and one patient was removed from the study due to inadequate analgesia. We conclude that fentanyl is not recommended for routine PCA use following Caesarean section.</description><identifier>ISSN: 0832-610X</identifier><identifier>EISSN: 1496-8975</identifier><identifier>DOI: 10.1007/BF03010570</identifier><identifier>PMID: 7889583</identifier><identifier>CODEN: CJOAEP</identifier><language>eng</language><publisher>Toronto, ON: Canadian Anesthesiologists' Society</publisher><subject>Adult ; Analgesia, Obstetrical - methods ; Analgesia, Patient-Controlled - methods ; Analgesics ; Anesthesia, General ; Anesthesia, Obstetrical ; Biological and medical sciences ; Cesarean Section ; Double-Blind Method ; Female ; Fentanyl - administration & dosage ; Fentanyl - adverse effects ; Humans ; Medical sciences ; Morphine - administration & dosage ; Morphine - adverse effects ; Nausea - chemically induced ; Neuropharmacology ; Pain Measurement ; Pain, Postoperative - prevention & control ; Patient Satisfaction ; Pharmacology. Drug treatments ; Pregnancy ; Prospective Studies ; Pruritus - chemically induced ; Sleep Stages - drug effects ; Vomiting - chemically induced</subject><ispartof>Canadian journal of anaesthesia, 1995, Vol.42 (1), p.41-45</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c347t-d7dfb4a469da55220f57fb791b87cd94dfafe11395ce86cdacdc81d7b07921ba3</citedby><cites>FETCH-LOGICAL-c347t-d7dfb4a469da55220f57fb791b87cd94dfafe11395ce86cdacdc81d7b07921ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,4036,4037,23909,23910,25118,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3361906$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7889583$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HOWELL, P. R</creatorcontrib><creatorcontrib>GAMBLING, D. R</creatorcontrib><creatorcontrib>PAVY, T</creatorcontrib><creatorcontrib>MCMORLAND, G</creatorcontrib><creatorcontrib>DOUGLAS, M. J</creatorcontrib><title>Patient-controlled analgesia following caesarean section under general anaesthesia : a comparison of fentanyl with morphine</title><title>Canadian journal of anaesthesia</title><addtitle>Can J Anaesth</addtitle><description>This prospective, randomised, double-blind study compared PCA fentanyl with PCA morphine for post-Caesarean section analgesia. Following a standardised general anaesthetic, 37 women were allocated to receive either fentanyl (n = 18) or morphine (n = 19). The PCA was commenced after the women had been made comfortable in the postanaesthetic recovery room with the appropriate opioid solution (mean dose required = fentanyl 375 micrograms or morphine 16 mg). Initial PCA settings were bolus 1 ml (fentanyl 25 micrograms or morphine 1 mg), lockout time ten minutes, and no background infusion. Both analgesic solutions provided effective analgesia for a mean of 37 hr with high levels of patient satisfaction, and there were no differences in VAS scores for pain and patient satisfaction, or for side effects (nausea, itch, and sleepiness) between fentanyl or morphine. However, more patients in the fentanyl group required supplementary boluses or alterations to the PCA settings (13/18 vs 4/19: P = 0.005), and one patient was removed from the study due to inadequate analgesia. We conclude that fentanyl is not recommended for routine PCA use following Caesarean section.</description><subject>Adult</subject><subject>Analgesia, Obstetrical - methods</subject><subject>Analgesia, Patient-Controlled - methods</subject><subject>Analgesics</subject><subject>Anesthesia, General</subject><subject>Anesthesia, Obstetrical</subject><subject>Biological and medical sciences</subject><subject>Cesarean Section</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Fentanyl - administration & dosage</subject><subject>Fentanyl - adverse effects</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Morphine - administration & dosage</subject><subject>Morphine - adverse effects</subject><subject>Nausea - chemically induced</subject><subject>Neuropharmacology</subject><subject>Pain Measurement</subject><subject>Pain, Postoperative - prevention & control</subject><subject>Patient Satisfaction</subject><subject>Pharmacology. Drug treatments</subject><subject>Pregnancy</subject><subject>Prospective Studies</subject><subject>Pruritus - chemically induced</subject><subject>Sleep Stages - drug effects</subject><subject>Vomiting - chemically induced</subject><issn>0832-610X</issn><issn>1496-8975</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM9LwzAUx4Moc04v3oUcPAnVpGmbxJsOp8JADwreymt-bJE2LUnHGP7zdm7M04P3_Xzfgw9Cl5TcUkL43eOMMEJJzskRGtNMFomQPD9GYyJYmhSUfJ2isxi_CSGiyMUIjbgQMhdsjH7eoXfG94lqfR_aujYag4d6YaIDbIdFu3Z-gRWYCMGAx9Go3rUer7w2AS-MNwHqbcfEfvnXuseAVdt0EFwcwNZiO3wAv6nx2vVL3LShWzpvztGJhTqai_2coM_Z08f0JZm_Pb9OH-aJYhnvE821rTLICqkhz9OU2JzbiktaCa60zLQFayhlMldGFEqD0kpQzSvCZUorYBN0s7urQhtjMLbsgmsgbEpKyq3A8l_gAF_t4G5VNUYf0L2xIb_e5xAV1DaAVy4eMMYKKknBfgGUwntW</recordid><startdate>1995</startdate><enddate>1995</enddate><creator>HOWELL, P. R</creator><creator>GAMBLING, D. R</creator><creator>PAVY, T</creator><creator>MCMORLAND, G</creator><creator>DOUGLAS, M. J</creator><general>Canadian Anesthesiologists' Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1995</creationdate><title>Patient-controlled analgesia following caesarean section under general anaesthesia : a comparison of fentanyl with morphine</title><author>HOWELL, P. R ; GAMBLING, D. R ; PAVY, T ; MCMORLAND, G ; DOUGLAS, M. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-d7dfb4a469da55220f57fb791b87cd94dfafe11395ce86cdacdc81d7b07921ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adult</topic><topic>Analgesia, Obstetrical - methods</topic><topic>Analgesia, Patient-Controlled - methods</topic><topic>Analgesics</topic><topic>Anesthesia, General</topic><topic>Anesthesia, Obstetrical</topic><topic>Biological and medical sciences</topic><topic>Cesarean Section</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Fentanyl - administration & dosage</topic><topic>Fentanyl - adverse effects</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Morphine - administration & dosage</topic><topic>Morphine - adverse effects</topic><topic>Nausea - chemically induced</topic><topic>Neuropharmacology</topic><topic>Pain Measurement</topic><topic>Pain, Postoperative - prevention & control</topic><topic>Patient Satisfaction</topic><topic>Pharmacology. Drug treatments</topic><topic>Pregnancy</topic><topic>Prospective Studies</topic><topic>Pruritus - chemically induced</topic><topic>Sleep Stages - drug effects</topic><topic>Vomiting - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HOWELL, P. R</creatorcontrib><creatorcontrib>GAMBLING, D. R</creatorcontrib><creatorcontrib>PAVY, T</creatorcontrib><creatorcontrib>MCMORLAND, G</creatorcontrib><creatorcontrib>DOUGLAS, M. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Canadian journal of anaesthesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HOWELL, P. R</au><au>GAMBLING, D. R</au><au>PAVY, T</au><au>MCMORLAND, G</au><au>DOUGLAS, M. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patient-controlled analgesia following caesarean section under general anaesthesia : a comparison of fentanyl with morphine</atitle><jtitle>Canadian journal of anaesthesia</jtitle><addtitle>Can J Anaesth</addtitle><date>1995</date><risdate>1995</risdate><volume>42</volume><issue>1</issue><spage>41</spage><epage>45</epage><pages>41-45</pages><issn>0832-610X</issn><eissn>1496-8975</eissn><coden>CJOAEP</coden><abstract>This prospective, randomised, double-blind study compared PCA fentanyl with PCA morphine for post-Caesarean section analgesia. Following a standardised general anaesthetic, 37 women were allocated to receive either fentanyl (n = 18) or morphine (n = 19). The PCA was commenced after the women had been made comfortable in the postanaesthetic recovery room with the appropriate opioid solution (mean dose required = fentanyl 375 micrograms or morphine 16 mg). Initial PCA settings were bolus 1 ml (fentanyl 25 micrograms or morphine 1 mg), lockout time ten minutes, and no background infusion. Both analgesic solutions provided effective analgesia for a mean of 37 hr with high levels of patient satisfaction, and there were no differences in VAS scores for pain and patient satisfaction, or for side effects (nausea, itch, and sleepiness) between fentanyl or morphine. However, more patients in the fentanyl group required supplementary boluses or alterations to the PCA settings (13/18 vs 4/19: P = 0.005), and one patient was removed from the study due to inadequate analgesia. We conclude that fentanyl is not recommended for routine PCA use following Caesarean section.</abstract><cop>Toronto, ON</cop><pub>Canadian Anesthesiologists' Society</pub><pmid>7889583</pmid><doi>10.1007/BF03010570</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0832-610X |
ispartof | Canadian journal of anaesthesia, 1995, Vol.42 (1), p.41-45 |
issn | 0832-610X 1496-8975 |
language | eng |
recordid | cdi_crossref_primary_10_1007_BF03010570 |
source | MEDLINE; SpringerLink Journals |
subjects | Adult Analgesia, Obstetrical - methods Analgesia, Patient-Controlled - methods Analgesics Anesthesia, General Anesthesia, Obstetrical Biological and medical sciences Cesarean Section Double-Blind Method Female Fentanyl - administration & dosage Fentanyl - adverse effects Humans Medical sciences Morphine - administration & dosage Morphine - adverse effects Nausea - chemically induced Neuropharmacology Pain Measurement Pain, Postoperative - prevention & control Patient Satisfaction Pharmacology. Drug treatments Pregnancy Prospective Studies Pruritus - chemically induced Sleep Stages - drug effects Vomiting - chemically induced |
title | Patient-controlled analgesia following caesarean section under general anaesthesia : a comparison of fentanyl with morphine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A37%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patient-controlled%20analgesia%20following%20caesarean%20section%20under%20general%20anaesthesia%20:%20a%20comparison%20of%20fentanyl%20with%20morphine&rft.jtitle=Canadian%20journal%20of%20anaesthesia&rft.au=HOWELL,%20P.%20R&rft.date=1995&rft.volume=42&rft.issue=1&rft.spage=41&rft.epage=45&rft.pages=41-45&rft.issn=0832-610X&rft.eissn=1496-8975&rft.coden=CJOAEP&rft_id=info:doi/10.1007/BF03010570&rft_dat=%3Cpubmed_cross%3E7889583%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/7889583&rfr_iscdi=true |